ARX788 Combo Outperforms Standard HER2+ Breast Cancer Therapy
In a groundbreaking phase 2b clinical trial published in Nature Communications, researchers have explored an innovative therapeutic approach for HER2-positive breast cancer, comparing the efficacy...